[<sup>18</sup>F]FMISO PET in metastatic neuroendocrine tumours: a pilot study.
Only one of ten patients with DONUT lesions demonstrated increased [<sup>18</sup>F]FMISO uptake rate on delayed static imaging. In contrast, dynamic imaging demonstrated increased [<sup>18</sup>F]FMISO uptake rate in the region of [<sup>68</sup>Ga]DOTATATE photopenia on 8 of 10 patients. Future research using [<sup>18</sup>F]FMISO in NEN patients should incorporate dynamic imaging.
Authors
- Alireza Aslani (ORCID: https://orcid.org/0000-0002-2828-5488)
- Kathy Willowson (ORCID: https://orcid.org/0000-0002-2195-0596)
- Nick Pavlakis
- David Lok Hang Chan (ORCID: https://orcid.org/0000-0002-7773-3144)
- Connie I. Diakos (ORCID: https://orcid.org/0000-0002-8877-3440)
- Alice Conner (ORCID: https://orcid.org/0000-0002-1313-1582)
- Stephen John Clarke (ORCID: https://orcid.org/0000-0001-5817-1222)
- PAUL J. ROACH (ORCID: https://orcid.org/0000-0003-2504-0474)
- Dale L. Bailey (ORCID: https://orcid.org/0000-0001-9154-7957)
- Elizabeth Bailey (ORCID: https://orcid.org/0000-0003-3262-9607)
- Alexander Engel (ORCID: https://orcid.org/0000-0002-0786-2901)
- Elizabeth J. Bernard
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.22038/aojnmb.2025.83664.1611
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical Research Council
- National Health and Medical Research Council